ICH Reforming in Ways that Could Strengthen Harmonization Process
This article was originally published in The Gold Sheet
Executive Summary
Twenty-five years after its founding, the organization where the world’s foremost regulatory authorities and industry groups reach agreement on pharmaceutical quality guidelines will incorporate next year in Switzerland. The new Swiss association could strengthen the role of emerging-market authorities in global regulatory harmonization – at least those that meet its membership criteria.
You may also be interested in...
ICH To Partner For Training Of Regulators, Industry On Key Guidelines
The organization that works to harmonize drug review requirements across a growing number of regulatory authorities aims to partner with non-profit groups to train regulatory authorities and industry on its guidelines, starting with guidelines on stability testing, good clinical practice and good manufacturing practices for active pharmaceutical ingredients.
US Visa Concerns Led ICH To Choose Canadian Meeting Site
The US, one of ICH’s original three member authorities, was spurned in favor of Canada for the pharmaceutical regulatory harmonization initiative’s next meeting in the region because of some participants’ difficulties obtaining US visas.
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.